Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F0FZ
|
|||
| Former ID |
DNCL002448
|
|||
| Drug Name |
UNBS-5162
|
|||
| Synonyms |
UNBS-5162; 956590-23-1; UNBS5162; UNII-JY9JF7D78N; UNBS 5162; JY9JF7D78N; 1-(2-(2-(dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea; WCKZRLOUKYFJDY-UHFFFAOYSA-N; SCHEMBL4188839; SCHEMBL4188846; UNBS 5162; AOB6480; EX-A460; BCP23948; ZINC34894706; UNBS 5162;UNBS-5162; AKOS026750504; CS-3379; Urea, N-(2-(2-(dimethylamino)ethyl)-2,3-dihydro-1,3-dioxo-1H-benz(de)isoquinolin-5-yl)-; HY-16509; DA-40120; QC-11792; KB-81386; BC600673; FT-0700422; Z-3223; J-690410
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 1 | [1] | |
| Company |
Drais Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H18N4O3
|
|||
| Canonical SMILES |
CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)NC(=O)N
|
|||
| InChI |
1S/C17H18N4O3/c1-20(2)6-7-21-15(22)12-5-3-4-10-8-11(19-17(18)24)9-13(14(10)12)16(21)23/h3-5,8-9H,6-7H2,1-2H3,(H3,18,19,24)
|
|||
| InChIKey |
WCKZRLOUKYFJDY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 956590-23-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027062) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.